Expert Exchange: Buy the turnaround in travel stocks, or avoid the turbulence? Philip Pepe explains
Philip Pepe discusses whether travel stocks are poised for a turnaround, the outlook for FY27 and where investors can find value.
Market Cap $194.1M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.17pm 26/06/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $2.40 | Day High | $2.63 | Day Low | $2.39 | |||
| Daily Volume | 628439 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $2.56 | 196 | 0 | $2.62 | 10000 | |
Directors & Senior Management
| Mr. Aaron Gray | Chief Executive Officer |
| Ms. Ann Esther Custin | Independent Non-Executive Director |
| Mr. Brant Schofield | Executive Vice President of Corporate Development |
| Mr. Brenton Walter | Financial Controller |
| Prof. Bruce G. Robinson | Non-Executive Chairman |
| Mr. Daniel Moore | President of DistributeRx |
| Mr. David Petrie | Non-Executive Director |
| Dr. Frank Casty | Executive VP, Global Head of R&D and Chief Medical Officer |
| Ms. Kimberly Parker | Executive VP & General Counsel |
| Mr. Kurt Reyes | Interim Global Head of People & Culture |
| Ms. Laura Loftus | Associate General Counsel & Company Secretary |
| Dr. Thomas Duthy | Manager of Investor Relations |
| Mr. Tony Ramy | Executive Vice President of Women's Health |
Data source: ADVFN
